Chlamydial etiology balanoposthitis therapy experience with combined topic steroid
https://doi.org/10.33667/2078-5631-2021-9-84-88
Abstract
The widespread spread of balanoposthitis necessitates the development of highly effective treatment methods. The experience of using combined topic steroid in a patient with balanoposthitis complicated by reactive arthritis and keratoderma is described. The high efficiency of treatment of balanoposthitis and keratoderma with a combined topical steroid with anti-inflammatory, antimicrobial, fungicidal and wound healing effects has been shown.
About the Authors
Yu. V. Nefedyeva
Chelyabinsk State Medical University, Chelyabinsk
Russian Federation
Russian Federation
Nefedyeva Yulia V.,PhD Med, associate prof. at Dept of Dermatovenereology
O. R. Ziganshin
Chelyabinsk State Medical University, Chelyabinsk
Russian Federation
Russian Federation
Ziganshin Oleg R.,DM Sci, prof., head of Dept of Dermatovenereology
N. A. Kosavchinskaya
Chelyabinsk Regional Clinical Skin and Venereal Diseases Dispensary, Chelyabinsk
Russian Federation
Russian Federation
Kosavchiskaya Nataliya A.,head of Dept of Round-the-Clock Inpatient Stay
V. V. Brik
Chelyabinsk Regional Clinical Skin and Venereal Diseases Dispensary, Chelyabinsk
Russian Federation
Russian Federation
Brik Victoria V.,dermatovenerologist at Dept of Round-the-Clock Inpatient Sta
References
1. Ryumin D. Treatment for balanitis and balanoposthitis. Vrach. 2006; 29–32.
2. Perlamutrov Yu.N., Chernova N. I. A modern approach to improving the therapy of balanoposthitis. Pharmacotherapy in dermatovenerology. 2010; 3: 61–65.
3. Kruglova L. S., Fyodorov D. V., Stenko A. G., Gryazeva N. V., Yakovlev A. B. Actual recommendations for multicomponent drug use in dermatology. Medical Alphabet. 2019; 2 (26): 67–72.
Review
For citations:
Nefedyeva Yu.V., Ziganshin O.R., Kosavchinskaya N.A., Brik V.V. Chlamydial etiology balanoposthitis therapy experience with combined topic steroid. Medical alphabet. 2021;(9):84-88. (In Russ.) https://doi.org/10.33667/2078-5631-2021-9-84-88
Views:
296
Email this article 